ABHILASH P NAMBIAR
Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology PHOENIX, AZ NPI 1013126440
Browse related groups: Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology AZ NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$5,381.78
- Category: General Payments
- Program years: PY2018–2024
- Record count: 163
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,195.69 across 47 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,195.69 | 47 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $134.70 | 6 |
| ACCURAY INCORPORATED | $119.09 | 1 |
| Daiichi Sankyo Inc. | $101.86 | 4 |
| Janssen Biotech, Inc. | $90.96 | 4 |
| Merck Sharp & Dohme Corporation | $82.55 | 3 |
| Acerta Pharma LLC | $71.70 | 3 |
| Lilly USA, LLC | $53.85 | 2 |
| SERVIER PHARMACEUTICALS LLC | $47.62 | 2 |
| ABBVIE INC. | $40.77 | 2 |
| TerSera Therapeutics LLC | $39.42 | 1 |
| Regeneron Healthcare Solutions, Inc. | $35.48 | 1 |
| PFIZER INC. | $34.47 | 2 |
| JAZZ PHARMACEUTICALS INC. | $33.88 | 1 |
| Verity Pharmaceuticals Inc. | $33.54 | 2 |
| Genmab U.S., Inc. | $25.45 | 1 |
| PharmaEssentia USA Corporation | $25.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.91 | 1 |
| EISAI INC. | $24.40 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $23.77 | 1 |
| Stemline Therapeutics Inc. | $22.77 | 1 |
| Myriad Genetic Laboratories, Inc. | $22.14 | 1 |
| Incyte Corporation | $21.74 | 1 |
| SOBI, INC | $20.92 | 1 |
| GENZYME CORPORATION | $20.50 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.77 | 1 |
| CHIESI USA, INC. | $14.90 | 1 |
| Karyopharm Therapeutics Inc. | $13.53 | 1 |
By program year
Records — PY2024 (47)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.